0001562180-24-002130.txt : 20240304
0001562180-24-002130.hdr.sgml : 20240304
20240304180128
ACCESSION NUMBER: 0001562180-24-002130
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240301
FILED AS OF DATE: 20240304
DATE AS OF CHANGE: 20240304
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Huang Jane
CENTRAL INDEX KEY: 0001683913
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39527
FILM NUMBER: 24716877
MAIL ADDRESS:
STREET 1: C/O MOURANT OZANNES CORPORATE SERVICES
STREET 2: 94 SOLARIS AVENUE
CITY: CAMANA BAY, GRAND CAYMAN
STATE: E9
ZIP: KY1-1108
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Prelude Therapeutics Inc
CENTRAL INDEX KEY: 0001678660
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 811384762
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 175 INNOVATION BOULEVARD
CITY: WILMINGTON
STATE: DE
ZIP: 19805
BUSINESS PHONE: (302) 467-1280
MAIL ADDRESS:
STREET 1: 175 INNOVATION BOULEVARD
CITY: WILMINGTON
STATE: DE
ZIP: 19805
FORMER COMPANY:
FORMER CONFORMED NAME: Prelude Therapeutics Inc.
DATE OF NAME CHANGE: 20160630
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0508
4
2024-03-01
false
0001678660
Prelude Therapeutics Inc
PRLD
0001683913
Huang Jane
C/O PRELUDE THERAPEUTICS INCORPORATED
175 INNOVATION BOULEVARD
WILMINGTON
DE
19805
false
true
false
false
President, CMO
false
Employee Stock Option (right to buy)
4.59
2024-03-01
4
A
false
175000.00
0.00
A
2034-02-28
Common Stock
175000.00
175000.00
D
The stock option vests as to 25% of the total shares on March 1, 2025, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
/s/ Laurent Chardonnet, Attorney-in-Fact
2024-03-04